Business
Super Bowl Winning Team Head Coach and MVP Press Conference
NFL Commissioner Roger Goodell and Kansas City Chiefs quarterback Patrick Mahomes (Photo by Don Juan Moore/Getty Images)

Private equity is eating sports

Private equity firms may soon own your favorite football franchise.

If you think private equity is eating everything, you're right.

Thursday, the Financial Times reported that private equity firms have been preparing funds to invest exclusively in the NFL. This marks a huge shift for the NFL, as it’s the only major American sports league without institutional investors.

Pitchbook published an excellent report in January breaking down private equity ownership stakes in the NBA, MLB, MLS, and NHL, showing that 31 teams across the four leagues have some level of private equity ownership.

Why are private equity firms interested in owning NFL teams? Because they are lucrative businesses, and team valuations have been soaring thanks to the league’s latest media rights contract.

Unlike other professional sports, such as baseball, where local media deals control the distribution of some games, all NFL games are packaged into league-wide deals with an equal revenue-sharing agreement between clubs.

In 2021, the NFL signed an 11-year, $110B contract that would begin in the 2023 season, and last season, each team took home roughly $400M from the league’s media and sponsorship deals.

Last year, Apollo Global Management cofounder Josh Harris bought the Washington Commanders for $6.05B last year, the highest price ever paid for any professional team in any league.

Rich, stable cash flows make NFL teams prized assets, but soaring valuations have reduced the number of qualified individuals that could afford a stake. Private equity firms, however, have billions of dollars to deploy, making them prime candidates to invest.

According to the Financial Times, the NFL is asking firms to create "American football-only funds" that wouldn't be able to invest in other sports leagues.

More Business

See all Business
business

Hims to stop offering copy of Wegovy pill following FDA scrutiny

Hims & Hers said it has decided to stop offering its newly launched copycat version of Novo Nordisk’s Wegovy pill, after the telehealth company drew criticism from the Food and Drug Administration. 

“Since launching the compounded semaglutide pill on our platform, we’ve had constructive conversations with stakeholders across the industry. As a result, we have decided to stop offering access to this treatment,” Hims wrote on X.

Shares of Hims are down double digits in premarket trading on Monday, while Novo Nordisk ADRs are up more than 6% as of 5:20 a.m. ET.

On Friday afternoon, the FDA said it would take “decisive steps” to restrict GLP-1 compounding. Department of Health and Human Services General Counsel Mike Stuart said on social media Friday he had referred Hims to the Department of Justice “for investigation for potential violations by Hims of the Federal Food, Drug, and Cosmetic Act and applicable Title 18 provisions.”

Hims launched the product last week, a seeming copy of a recently released and patented drug, which immediately drew fire from Novo Nordisk and regulators.

Shares of Hims are down double digits in premarket trading on Monday, while Novo Nordisk ADRs are up more than 6% as of 5:20 a.m. ET.

On Friday afternoon, the FDA said it would take “decisive steps” to restrict GLP-1 compounding. Department of Health and Human Services General Counsel Mike Stuart said on social media Friday he had referred Hims to the Department of Justice “for investigation for potential violations by Hims of the Federal Food, Drug, and Cosmetic Act and applicable Title 18 provisions.”

Hims launched the product last week, a seeming copy of a recently released and patented drug, which immediately drew fire from Novo Nordisk and regulators.

Hims oral semaglutide

Hims, long flying under regulators’ radar, finally strikes a nerve with its Wegovy pill copy

It’s unclear if the pill Hims is selling works or if the FDA will allow it.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.